SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/11/22 Asensus Surgical, Inc. 8-K:2,9 8/08/22 13:547K RDG Filings/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 27K 2: EX-99.1 Miscellaneous Exhibit HTML 307K 3: EX-99.2 Miscellaneous Exhibit HTML 51K 8: R1 Document And Entity Information HTML 46K 11: XML IDEA XML File -- Filing Summary XML 12K 9: XML XBRL Instance -- asxc20220809_8k_htm XML 13K 10: EXCEL IDEA Workbook of Financial Reports XLSX 8K 5: EX-101.DEF XBRL Definitions -- asxc-20220808_def XML 37K 6: EX-101.LAB XBRL Labels -- asxc-20220808_lab XML 48K 7: EX-101.PRE XBRL Presentations -- asxc-20220808_pre XML 36K 4: EX-101.SCH XBRL Schema -- asxc-20220808 XSD 14K 12: JSON XBRL Instance as JSON Data -- MetaLinks 12± 19K 13: ZIP XBRL Zipped Folder -- 0001437749-22-020155-xbrl Zip 50K
i Delaware
(State or other jurisdiction of
incorporation or organization) |
i 0-19437
(Commission
File Number)
|
i 11-2962080
(I.R.S. Employer
Identification Number) |
i ☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
i ☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
i ☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
i ☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading symbol
|
Name of each exchange on which registered
|
||
i Common Stock
$0.001 par value per share
|
i ASXC
|
i NYSE American
|
Item 2.02
|
Results of Operations and Financial Condition
|
Item 9.01
|
Financial Statements and Exhibits.
|
(d)
|
Exhibit
|
Exhibit No. | Description | |
99.1 | Press release dated August 8, 2022 | |
99.2 | August 8, 2022 conference call transcript | |
104 | Cover Page Interactive Data File (formatted in inline XBRL) |
ASENSUS SURGICAL, INC.
|
|||
Date: August 11, 2022
|
By:
|
||
Executive Vice President and Chief Financial Officer
|
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 8/11/22 | |||
For Period end: | 8/8/22 | 10-Q | ||
7/26/22 | ||||
6/30/22 | 10-Q | |||
List all Filings |